Acumen Pharmaceuticals's total assets for Q1 2026 were $133.63M, an increase of 8.79% from the previous quarter. ABOS total liabilities were $46.15M for the fiscal quarter, a -11.93% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.